Aarey Drugs & Pharmaceuticals Ltd - Stock Valuation and Financial Performance

BSE: 524412 | NSE: AAREYDRUGS | Pharmaceuticals & Drugs | Small Cap

Aarey Drugs & Pharma Share Price

40.80 1.72 4.40%
as on 19-Mar'24 10:07

DeciZen - make an informed investing decision on Aarey Drugs & Pharma

M-Cap below 100cr DeciZen not available

Aarey Drugs & Pharmaceuticals stock performance -

mw4me loader
P/E Ratio (SA):
26.25
Market Cap:
99.2 Cr.
52-wk low:
21.9
52-wk high:
68

Is Aarey Drugs & Pharmaceuticals Ltd an attractive stock to invest in?

1. Is Aarey Drugs & Pharmaceuticals Ltd a good quality company?

Past 10 year’s financial track record analysis by Moneyworks4me indicates that Aarey Drugs & Pharmaceuticals Ltd is a below average quality company.

2. Is Aarey Drugs & Pharmaceuticals Ltd undervalued or overvalued?

The key valuation ratios of Aarey Drugs & Pharmaceuticals Ltd's currently when compared to its past seem to suggest it is in the Fair zone.

3. Is Aarey Drugs & Pharmaceuticals Ltd a good buy now?

The Price Trend analysis by MoneyWorks4Me indicates it is Weak which suggest that the price of Aarey Drugs & Pharmaceuticals Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.

10 Year X-Ray of Aarey Drugs & Pharma:

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Aarey Drugs & Pharmaceuticals Ltd has not performed well majority of the past ten years indicating its past ten year financial track record is not good

Value Creation

Value Creation Index Colour Code Guide

Mar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23TTM
ROCE % 4.3%4.8%5.1%15.3%10.2%8.7%6.6%7.2%6.5%4.3%-
Value Creation
Index
-0.7-0.7-0.60.1-0.3-0.4-0.5-0.5-0.5-0.7-

Growth Parameters

Growth Parameters Colour Code Guide

Sales 200213246396349355300348493419343
Sales YoY Gr.-6.9%15.3%60.9%-12%1.7%-15.4%16.1%41.4%-15%-
Adj EPS 0.60.60.832.62.82.52.82.61.61.5
YoY Gr.-5%20.6%297.4%-15.6%9.4%-11.1%12.1%-7.6%-37.4%-
BVPS (₹) 20.52121.826.633.33638.541.343.945.347.6
Adj Net
Profit
11.11.35.566.55.86.56.54.14
Cash Flow from Ops. -0.43.35.70.6-20.40.72.95.50.5-1.3-
Debt/CF from Ops. -13.63.42.616.6-0.223.56.33.328.4-29.4-

CAGR

CAGR Colour Code Guide

9 Years 5 Years 3 Years 1 Years
Sales 8.6%3.7%11.8%-15%
Adj EPS 11.6%-8.8%-13.4%-37.4%
BVPS9.2%6.4%5.6%3.4%
Share Price 14.1% 7.1% 18.1% 55.4%

Key Financial Parameters

Performance Ratio Colour Code Guide

Mar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23TTM
Return on
Equity %
333.512.79.27.86.56.86.13.53.2
Op. Profit
Mgn %
0.70.60.42.42.22.21.11.32.321.1
Net Profit
Mgn %
0.50.50.51.41.71.81.91.91.311.1
Debt to
Equity
0.20.30.40.200.20.20.20.10.3-
Working Cap
Days
182179166112148147191209166221123
Cash Conv.
Cycle
7273624637454385857

Recent Performance Summary

Sales growth is growing at healthy rate in last 3 years 11.77%

Return on Equity has declined versus last 3 years average to 3.20%

Net Profit has been subdued in last 3 years -13.41%

Sales growth is not so good in last 4 quarters at -6.83%

Latest Financials - Aarey Drugs & Pharmaceuticals Ltd.

Standalone Consolidated
TTM EPS (₹) 1.5 -
TTM Sales (₹ Cr.) 343 -
BVPS (₹.) 47.6 -
Reserves (₹ Cr.) 95 -
P/BV 0.82 -
PE 26.25 -
From the Market
52 Week Low / High (₹) 21.90 / 68.00
All Time Low / High (₹) 0.50 / 143.95
Market Cap (₹ Cr.) 99.2
Equity (₹ Cr.) 25.4
Face Value (₹) 10
Industry PE 47.5

Management X-Ray of Aarey Drugs & Pharma:

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged *0.000.000.000.000.000.000.000.000.000.00
* Pledged shares as % of Promoter's holding (%)

Event Update

Login/Register to view analysis.

Analyst's Notes

Key Ratios of Aarey Drugs & Pharma

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)
PARTICULARSMar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23
Sales199.73213.44246.03395.97348.63354.71300.09348.42492.76418.96
Operating Expenses 198.40212.08245.02386.36340.99346.82296.86343.77481.37411.23
Manufacturing Costs1.150.490.830.040.101.981.554.558.037.79
Material Costs194.53209.67241.99382.99337.36340.97290.18334.50466.11397.54
Employee Cost 0.410.260.260.340.350.370.290.200.670.63
Other Costs 2.291.661.9233.173.504.834.526.555.29
Operating Profit 1.331.361.019.617.647.893.234.6511.407.72
Operating Profit Margin (%) 0.7%0.6%0.4%2.4%2.2%2.2%1.1%1.3%2.3%1.8%
Other Income 1.582.593.143.343.184.346.697.012.672.73
Interest 0.951.491.724.331.922.231.792.442.042.87
Depreciation 0.621.050.620.640.711.010.890.921.991.57
Exceptional Items 0000000000
Profit Before Tax 1.341.411.817.988.198.997.248.3010.046.01
Tax 0.290.320.522.502.012.441.451.793.482.24
Profit After Tax 1.051.091.295.476.186.545.796.516.553.77
PAT Margin (%) 0.5%0.5%0.5%1.4%1.8%1.8%1.9%1.9%1.3%0.9%
Adjusted EPS (₹)0.60.70.83.02.62.82.52.82.61.5
Dividend Payout Ratio (%)0%0%0%0%0%4%0%0%0%0%

Balance Sheet

(All Figures are in Crores.)
PARTICULARSMar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23

Equity and Liabilities

Shareholders Fund 34.5235.4136.7048.1677.9384.2490.0396.55111.32115.09
Share Capital 16.8116.8116.8118.0823.3823.3823.3823.3825.3825.38
Reserves 17.7118.5919.8830.0754.5560.8566.6573.1685.9489.71
Minority Interest0000000000
Debt5.7211.0214.5410.393.2416.1617.8918.0214.1637.72
Long Term Debt0.0100.090.070.060.040.0203.344.36
Short Term Debt5.7011.0214.4510.323.1816.1217.8718.0210.8233.36
Trade Payables64.0867.1471.9574.5577.5837.2877.75110.34109.66127.33
Others Liabilities 2.571.381.829.4011.058.048.418.1310.0211.18
Total Liabilities 106.89114.95125142.50169.79145.72194.08233.04245.17291.32

Fixed Assets

Gross Block14.0116.7719.3524.2824.5626.1327.0529.9332.1333.17
Accumulated Depreciation9.6210.8811.5012.1412.8513.8614.7515.6717.6619.23
Net Fixed Assets4.385.897.8512.1511.7112.2712.3014.2614.4713.94
CWIP 0.330000.3400000
Investments 0.440.440.440.440.440.440.440.400.400.40
Inventories5.134.172.085.2114.7721.251718.4613.6828.82
Trade Receivables64.8566.7172.4881.8695.30105.7496.13162.01136.28189.78
Cash Equivalents 0.850.171.621.043.390.370.500.650.190.71
Others Assets30.9037.5740.5341.8143.845.6467.7137.2580.1457.68
Total Assets 106.89114.95125142.50169.79145.72194.08233.04245.17291.32

Cash Flow

(All Figures are in Crores.)
PARTICULARSMar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23
Cash Flow From Operating Activity -0.423.255.660.62-20.350.692.865.480.50-1.28
PBT 1.341.411.817.988.198.997.248.3010.036.01
Adjustment 1.602.572.375.022.633.242.683.353.994.44
Changes in Working Capital -3.36-0.731.48-10.27-28.56-9.29-5.56-4.51-9.93-9.45
Tax Paid 000-2.10-2.61-2.25-1.50-1.66-3.59-2.28
Cash Flow From Investing Activity 1.86-2.43-2.58-4.96-0.60-1.23-0.92-2.88-3.210.44
Capex -0.93-2.43-2.58-4.94-0.62-1.23-0.92-2.88-2.20-1.04
Net Investments 2.790000.02000-1.011.49
Others 000-0.03000000
Cash Flow From Financing Activity -1.10-1.50-1.633.7523.31-2.48-1.80-2.452.251.35
Net Proceeds from Shares 0008.1523.5900000
Net Proceeds from Borrowing -0.16-0.010.09-0.010000-3.981.02
Interest Paid -0.95-1.49-1.72-4.33-1.92-2.23-1.79-2.43-2-2.87
Dividend Paid 00000-0.230000
Others 000-0.051.63-0.02-0.02-0.028.233.20
Net Cash Flow 0.34-0.681.45-0.582.35-3.020.130.15-0.460.51
PARTICULARSMar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23
Ratios
ROE (%)3.13.123.5812.99.88.076.656.986.313.33
ROCE (%)5.836.697.2322.2114.1412.058.489.469.876.27
Asset Turnover Ratio1.871.922.052.962.242.251.771.632.061.56
PAT to CFO Conversion(x)-0.42.984.390.11-3.290.110.490.840.08-0.34
Working Capital Days
Receivable Days1201121037193103123135110142
Inventory Days12853101923191219
Payable Days1201141057082617210386109

Aarey Drugs & Pharmaceuticals Ltd Stock News

Aarey Drugs & Pharmaceuticals Ltd FAQs

Company share prices are keep on changing according to the market conditions. The closing price of Aarey Drugs & Pharma on 19-Mar-2024 10:07 is ₹40.80.
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 19-Mar-2024 10:07 the market cap of Aarey Drugs & Pharma stood at ₹99.20.
The latest P/E ratio of Aarey Drugs & Pharma as of 19-Mar-2024 10:07 is 26.25.
The latest P/B ratio of Aarey Drugs & Pharma as of 19-Mar-2024 10:07 is 0.82.
The 52-week high of Aarey Drugs & Pharma is ₹68.00 and the 52-week low is ₹21.90.
The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Aarey Drugs & Pharma is ₹343.4 ( Cr.) .

About Aarey Drugs & Pharmaceuticals Ltd

Aarey Drugs & Pharmaceuticals Ltd. was established in 1990. The company is engaged in the manufacturing of drugs and intermediates such as metronidazole, metronidazole benzoate, methyl, and nitro imidazole. The company is based in Thane, India.

The  company also export its products to various other countries like Germany, Sri Lanka, Pakistan, Nepal and a number of African countries and is looking to establish its trade relations in other parts of the world as well.

Product range of the company includes: API/Intermediate

  • Metronidazol
  • Metronidazole Benzoate
  • 2 Methyl -5-Nitro Imidazole

Drug deliveryPharmaceuticals / Therapeutics

Therapeutic targets of the company's products are:

  • Allergy
  • Dermatology
  • Infectious Diseases

Recent development

Aarey Drugs & Pharmaceuticals  has recently informed that  Atul A Zatakia has resigned from the Company as a Director with effect from March 01, 2009.  

Read More Read Less
You have 2 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.